Tuesday, May 21, 2024 5:32:59 PM
This company has the platform to produce a promising oral GLP1 option right now.
You also get some free shots at the goal in 4 other indications.
Recent RANI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:03:53 PM
- Rani Therapeutics to Participate in May Investor Conferences • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM
- Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024 • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:09:53 PM
- Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 05/06/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:04:34 PM
- Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 03/20/2024 08:05:00 PM
- Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/15/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 01:10:21 PM
- Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:06:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:05:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 01:05:09 PM
- Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist • GlobeNewswire Inc. • 12/14/2023 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 10:18:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 01:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 01:00:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:10:09 PM
- Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update • GlobeNewswire Inc. • 11/08/2023 09:05:00 PM
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM